IN THE NEWS
May 6, 2026
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
Forbes
The safety and effectiveness of the Symani Surgical System for lymphatic reconstruction for brain disease has not yet been established. The FDA has not cleared the use of the Symani Surgical System for head and neck lymphatic surgery.
Related News
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI Introduces World’s First Microsurgical Suture for Robotics
MMI Introduces World’s First Microsurgical Suture for Robotics
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
